Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Holding structure for a touch panel
Hard disk drives having different rotational speeds
Method for processing power headroom and terminal thereof
Methods of implanting dopant ions
Systems and methods for simultaneously configuring multiple independent backups
  Randomly Featured Patents
Gas-measuring system
Device for attaching a prosthesis
Management of multiple buffers and video decoders in progressive digital video decoder
Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate
Long-lasting phosphor, powdered long-lasting phosphor and method for manufacturing the powdered long-lasting phosphor
Plungerless syringe
Churning loss reduction means for gear type devices
Icon for a computer display
Secure digital input/output card
Electronic game apparatus and method providing a secondary game triggered apart from a primary game